feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Heartburn's Deadly Secret: Oesophageal Cancer Rise

Heartburn's Deadly Secret: Oesophageal Cancer Rise

3 Feb

•

Summary

  • Stage 4 oesophageal cancer diagnoses increased to 37% in England by 2022.
  • Persistent heartburn may signal oesophageal cancer, a 'forgotten cancer'.
  • One-year survival drops significantly from 89% at stage 1 to 26% at stage 4.
Heartburn's Deadly Secret: Oesophageal Cancer Rise

Andrew Stanley's personal battle with oesophageal cancer underscores a worrying trend in England, where the proportion of diagnoses at stage 4 has climbed to 37% in 2022 from 25% in 2013. This advanced stage often means the disease has spread and is incurable.

Action Against Heartburn, a charity, is raising awareness about oesophageal cancer, often called the 'forgotten cancer'. They highlight that persistent heartburn, especially when accompanied by difficulty swallowing, should prompt medical consultation. Andrew's own journey involved years of occasional heartburn before seeking help for swallowing issues, leading to a stage 4 diagnosis.

Survival rates for oesophageal cancer are starkly linked to early detection. While one-year survival is 89% at stage 1, it plummets to 26% at stage 4. Fewer than 20% of individuals diagnosed in the UK, where around 9,200 new cases occur annually, survive for more than five years.

trending

Nvidia share price drops sharply

trending

Anthropic AI triggers IT selloff

trending

India U19 World Cup final

trending

UGC NET December Result Soon

trending

GTA 6 release confirmed

trending

Raducanu recovers, wins quarter-final

trending

Nasdaq considers 'fast entry' rule

trending

Ronaldo trains with Al Nassr

trending

T20 World Cup 2026 details

Despite initial limited treatment options, Andrew participated in a clinical trial in Oxford, which proved successful, leading to remission. He shares his story to offer hope and emphasize the critical need for greater public and medical recognition of oesophageal cancer symptoms.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Persistent heartburn can be a warning sign of oesophageal cancer, often referred to as the 'forgotten cancer', and should prompt medical consultation.
The proportion of oesophageal cancers diagnosed at stage 4 in England increased from 25% in 2013 to 37% in 2022, indicating more late-stage diagnoses.
One-year survival for oesophageal cancer is 89% if diagnosed at stage 1 but drops significantly to 26% if diagnosed at stage 4.

Read more news on

Healthside-arrowEnglandside-arrow

You may also like

Govt. Funds Cancer Patient Travel: No More Debt

1 day ago • 5 reads

article image

Personal Trainer's Life Saved by Free NHS Test

1 day ago • 5 reads

article image

Cancer Survivor Cycles UK on Chopper for Charity

2 Feb • 14 reads

article image

Teacher's Cancer Battle After 20 Doctor Visits

26 Jan • 60 reads

article image

Miracle Drug Helps Boy Walk After Rare Genetic Disorder

1 Jan • 194 reads

article image